Royalty Pharma plc (NASDAQ:RPRX) Stake Boosted by Geode …

Dec 16, 2024 · Geode Capital Management LLC boosted its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 6.1% in the 3rd quarter, according to its most recent filing …

1%
OFF

Royalty Pharma Plc (NASDAQ:RPRX) Stake Boosted By Geode …

2 weeks from now

Dec 16, 2024 · Geode Capital Management LLC boosted its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 6.1% in the 3rd quarter, according to its most recent filing …

marketbeat.com

$100
OFF

Royalty Pharma Announces Transformative Step In Company’s …

2 weeks from now

4 days ago · Royalty Pharma will acquire the Manager for approximately 24.5 million shares of Royalty Pharma equity that will vest over 5 to 9 years, approximately $100 million in cash [1], …

royaltypharma.com

$29.49
OFF

Here’s Why Royalty Pharma Plc (RPRX) Led This Week’s Rally

2 weeks from now

2 days ago · Royalty Pharma plc (NASDAQ:RPRX) saw its share price increase by 14.26 percent to end at $29.49 apiece versus the $25.81 posted the week prior, following news that it was …

yahoo.com

$2.36
OFF

Pallas Capital Advisors LLC Invests $2.36 Million In Royalty Pharma …

2 weeks from now

2 days ago · Pallas Capital Advisors LLC purchased a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the fourth quarter, according to the company in its most …

marketbeat.com

1%
OFF

Royalty Pharma (NASDAQ:RPRX) Upgraded At TD Cowen

2 weeks from now

Dec 27, 2024 · Finally, Geode Capital Management LLC boosted its stake in Royalty Pharma by 6.1% during the third quarter. Geode Capital Management LLC now owns 7,265,786 shares of …

tickerreport.com

$3
OFF

Royalty Pharma To Buy Its External Manager, Announces $3B Share …

2 weeks from now

4 days ago · Royalty Pharma plc said the Board of Directors has agreed to acquire its external manager, RP Management, LLC. On a financial basis, the acquisition is expected to reduce …

seekingalpha.com

51%
OFF

Royalty Pharma Plc (NASDAQ:RPRX) Is Favoured By Institutional …

2 weeks from now

Dec 24, 2024 · A total of 10 investors have a majority stake in the company with 51% ownership. ... To get a sense of who is truly in control of Royalty Pharma plc (NASDAQ:RPRX), it is …

yahoo.com

$0.96
OFF

Royalty Pharma (RPRX) Stock Price, News & Analysis - MarketBeat

2 weeks from now

5 days ago · Royalty Pharma plc (NASDAQ:RPRX) released its quarterly earnings results on Thursday, August, 8th. The biopharmaceutical company reported $0.96 earnings per share for …

marketbeat.com

$24.05
OFF

JPMorgan Chase & Co. Trims Stake In Royalty Pharma Plc …

2 weeks from now

Jan 7, 2025 · Royalty Pharma plc has a 12-month low of $24.05 and a 12-month high of $31.66. The firm has a market cap of $15.17 billion, a price-to-earnings ratio of 13.34, a PEG ratio of …

etfdailynews.com

50%
OFF

How Much Of Royalty Pharma Plc (NASDAQ:RPRX) Do Insiders Own?

2 weeks from now

Sep 13, 2021 · Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions. It looks like hedge funds own 5.3% of Royalty …

nasdaq.com

$25.23
OFF

Royalty Pharma (NASDAQ:RPRX) Raised To “Strong-Buy” At TD …

2 weeks from now

Dec 26, 2024 · NASDAQ:RPRX opened at $25.23 on Tuesday. The company has a market cap of $14.87 billion, a PE ratio of 13.07, a P/E/G ratio of 4.36 and a beta of 0.46. The business’s 50 …

etfdailynews.com

3%
OFF

RPRX News Today | Why Did Royalty Pharma Stock Go Down …

2 weeks from now

Jan 6, 2025 · UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 6.3% during the …

marketbeat.com

$29.49
OFF

Here’s Why Royalty Pharma Plc (RPRX) Led This Week’s Rally - MSN

2 weeks from now

Royalty Pharma plc (NASDAQ:RPRX) saw its share price increase by 14.26 percent to end at $29.49 apiece versus the $25.81 posted the week prior, following news that it was set to …

msn.com

3%
OFF

Royalty Pharma Plc (NASDAQ:RPRX) Shares Sold By JPMorgan …

2 weeks from now

Jan 7, 2025 · JPMorgan Chase & Co. lessened its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 83.3% in the third quarter, according to the company in its most recent …

marketbeat.com

FAQs about Royalty Pharma plc (NASDAQ:RPRX) Stake Boosted by Geode … Coupon?

Why did Royalty Pharma (RPRX) increase its share price?

Royalty Pharma plc (NASDAQ:RPRX) saw its share price increase by 14.26 percent to end at $29.49 apiece versus the $25.81 posted the week prior, following news that it was set to acquire its external manager RP Management, as it seeks to simplify its corporate structure. ...

How did Royalty Pharma (RPRX) perform in the quarter?

Royalty Pharma plc (NASDAQ:RPRX) announced its quarterly earnings results on Thursday, August, 8th. The biopharmaceutical company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.95 by $0.01. The biopharmaceutical company earned $537 million during the quarter, compared to analyst estimates of $600.83 million. ...

Who is Royalty Pharma (RPRX)?

Begin your TipRanks Premium journey today. Royalty Pharma (RPRX) Company Description: New York-based Royalty Pharma Plc is a biopharmaceutical company, which is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry. ...

How did Royalty Pharma's stock perform in 2024?

Royalty Pharma's stock was trading at $28.09 at the beginning of 2024. Since then, RPRX stock has decreased by 11.6% and is now trading at $24.84. How were Royalty Pharma's earnings last quarter? Royalty Pharma plc (NASDAQ:RPRX) announced its quarterly earnings results on Thursday, August, 8th. ...

Where can I buy Royalty Pharma stock?

Shares of RPRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Royalty Pharma own? ...

Does JPMorgan Chase own Royalty Pharma plc?

JPMorgan Chase & Co. lessened its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 83.3% during the third quarter, HoldingsChannel reports. The institutional investor owned 1,289,418 shares of the biopharmaceutical company’s stock after selling 6,449,863 shares during the quarter. ...